Evidence in favour
- Participation spans 6 named insiders rather than one filing source.
Company insider dossier
Hyperfine Inc insider intelligence
HYPR filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.
25/100
Concentrated distribution
56/100 confidence- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Latest evidence
- 24 Aug 2026
Investment committee read
Concentrated distribution
Priced common-share disposals are concentrated enough to warrant review, but they are not treated as a standalone bearish forecast.
Review exposure and filing contextDecision risks
- Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.
Price confirmation map
Weekly price with common-share events
Acquisitions and disposals are aligned to the nearest completed weekly bar.
Mar 2025Sep 2026
Weekly closeCommon-share acquisitionCommon-share disposal
Market confirmation
Price and trend context
- Latest close
- 0.7901 USD
- One-week move
- -2.9%
- Four-week move
- -11.5%
- Fair-value gap
- -27.4%
- Trend signal
- Inactive
- Relative strength
- -40.5
Directional balance
Controlled event mix
0.0%acquisition
- Acquisition events
- 0
- Disposal events
- 2
- Net value
- -$32.5K
Cadence
Twelve-week filing pressure
Volume shows attention. Controlled events determine direction.
029 Jun
006 Jul
013 Jul
020 Jul
027 Jul
003 Aug
010 Aug
017 Aug
224 Aug
031 Aug
007 Sep
014 Sep
Named participants
Insider conviction by person
DAHLDORF, JOHN TDirector500 events
FATTORI, RUTH ADirector500 events
ROTHBERG, JONATHAN MDirector, 10% Owner500 events
WOLTERMAN, DANDirector500 events
HALE, BRETTCFO and CAO252 events
TEISSEYRE, THOMASChief Operating Officer252 events
Evidence quality
Security and transaction context
Role architecture
Who is participating
Transaction evidence
Auditable HYPR filing ledger
Showing 1 to 9 of 9.
HALE, BRETTCFO and CAO
DisposalCommon equity
7345 sharesClass A Common Stock
$6.3KDirectional evidence
TEISSEYRE, THOMASChief Operating Officer
DisposalCommon equity
7345 sharesClass A Common Stock
$6.3KDirectional evidence
WOLTERMAN, DANDirector
AcquisitionOptions and derivatives
52600 sharesStock Options (right to buy)
Not reportedContext evidence
HALE, BRETTCFO and CAO
DisposalCommon equity
6047 sharesClass A Common Stock
$10.0KDirectional evidence
TEISSEYRE, THOMASChief Operating Officer
DisposalCommon equity
6047 sharesClass A Common Stock
$10.0KDirectional evidence
DAHLDORF, JOHN TDirector
AcquisitionOptions and derivatives
157700 sharesStock Options (right to buy)
Not reportedContext evidence
FATTORI, RUTH ADirector
AcquisitionOptions and derivatives
157700 sharesStock Options (right to buy)
Not reportedContext evidence
ROTHBERG, JONATHAN MDirector, 10% Owner
AcquisitionOptions and derivatives
157700 sharesStock Options (right to buy)
Not reportedContext evidence
WOLTERMAN, DANDirector
AcquisitionOptions and derivatives
157700 sharesStock Options (right to buy)
Not reportedContext evidence
Reading the dossier
Direction and confidence are separate
Conviction
The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.
Confidence
Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.
Disposals
Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.
Price confirmation
The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.
Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.